Amanote Research
Register
Sign In
Pnd117 - Physician Reported Adherence in Ms Patients Treated With Injectable Platform Therapies Versus Delayed-Release Dimethyl Fumarate: Findings From a Real-World Cross-Sectional Study
Value in Health
- United Kingdom
doi 10.1016/j.jval.2018.09.2082
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Date
October 1, 2018
Authors
M Rock
J Pike
E Jones
J Husbands
K Golden
A Gasik
Publisher
Elsevier BV
Related search
Pnd79 - Reduced Healthcare Resource Utilisation for Patients Treated With Delayed Release Dimethyl Fumarate vs Injectable Therapies: Findings From a Real-World Cross-Sectional Study of Ms Patients
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
A Retrospective Analysis of Real-World Discontinuation Rates With Delayed-Release Dimethyl Fumarate in Patients With Relapsing–Remitting Multiple Sclerosis
Neurology and Therapy
Neurology
Effectiveness of Delayed-Release Dimethyl Fumarate on Patient-Reported Outcomes and Clinical Measures in Patients With Relapsing–remitting Multiple Sclerosis in a Real-World Clinical Setting: PROTEC
Multiple Sclerosis Journal - Experimental, Translational and Clinical
Real-World Two-Year Treatment Patterns Among Patients With Psoriatic Arthritis Treated With Injectable Biologic Therapies
Current Medical Research and Opinion
Medicine
Consensus Management of Gastrointestinal Events Associated With Delayed-Release Dimethyl Fumarate: A Delphi Study
Neurology and Therapy
Neurology
Patient-Specific Factors Modulate Leukocyte Response in Dimethyl Fumarate Treated MS Patients
PLoS ONE
Multidisciplinary
Pnd8 - Peginterferon Beta-1a Is Associated With Reduced Relapse Rates and Hospitalisations Due to Relapse Compared With Other First-Line Injectable Therapies for Multiple Sclerosis: Findings From a Real-World Cross-Sectional Study
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Nursing Management of Gastrointestinal Adverse Events Associated With Delayed-Release Dimethyl Fumarate
Journal of Neuroscience Nursing
Endocrine
Medical
Autonomic Systems
Surgical Nursing
Neurology
Surgery
Gastrointestinal Tolerability of Delayed-Release Dimethyl Fumarate in a Multicenter, Open-Label Study of Patients With Relapsing Forms of Multiple Sclerosis (MANAGE)
International Journal of MS Care
Neurology
Specialized Nursing
Advanced
